Auriga Medical is also engaged in the development, production and commercialization of high-class radioactive pharmaceuticals. We specialize in working with medical technology companies and medical researchers and our aim is to develop isotope products for the treatment of new cancer therapies and other diseases. Our products are currently being applied in radioimmunotherapy and in the treatment of liver tumours. We are your expert partners in nuclear medicine and radiation therapy.
Our goal is to capitalize on our track record in the development of radioactive sources and the reliable supply of Y-90 chloride solution for clinical use. We offer reliable, on-time delivery of our radioisotope products for optimum patient care.
The photo features the Y-90 production facility of Eckert & Ziegler Nuclitec GmbH in Braunschweig.
The blue light is created by the "Cerenkov effect" of the beta radiation of Y-90.
For more information about Auriga Medical please visit www.radiopharma-gmbh.com
The blue light is created by the "Cerenkov effect" of the beta radiation of Y-90.
For more information about Auriga Medical please visit www.radiopharma-gmbh.com
